Get the latest news, insights, and market updates on MGX (Metagenomi, Inc.). Explore the news page 2 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue Estimates
Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -7.69% and -4.13%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock? Nov 5, 2025 - $MGX
Metagenomi taps Amazon's custom chips to develop gene-editing tools
SAN FRANCISCO (Reuters) -Biotech firm Metagenomi said it is using artificial intelligence chips from Amazon.com's cloud computing unit to power some of its work in developing gene-editing technologies. The work represents one of the first major uses of Amazon Web Services chips beyond chatbots and other products powered by large language models, with Metagenomi saying AWS's Inferentia chips had proven far more cost-effective than products from rivals like Nvidia. Emeryville, California-based firm Metagenomi is one of a number of companies working to develop tools to inject genetic material into the human body where it can edit genes to treat diseases. Oct 22, 2025 - $MGX
Promising Penny Stocks To Watch In October 2025
As the U.S. stock market navigates through a period of earnings reports and fluctuating commodity prices, investors continue to explore various avenues for potential growth. Penny stocks, often associated with smaller or newer companies, remain a relevant area of interest due to their potential for significant returns at lower price points. In this article, we examine three penny stocks that exhibit strong financial foundations and promising prospects in today's market landscape. Oct 22, 2025 - $MGX
September 2025's Top Penny Stocks To Consider
As the U.S. stock market experiences fluctuations following recent comments from Federal Reserve Chair Jerome Powell, investors are navigating a landscape marked by both record highs and cautious optimism. For those willing to explore beyond the well-known giants, penny stocks—typically representing smaller or newer companies—continue to hold intrigue with their potential for growth and affordability. In this article, we examine three penny stocks that stand out for their financial strength... Sep 23, 2025 - $MGX
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
Metagenomi (MGX) delivered earnings and revenue surprises of +20.59% and +20.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock? Aug 12, 2025 - $MGX
Metagenomi: Q2 Earnings Snapshot
EMERYVILLE, Calif. AP) — Metagenomi Inc. MGX) on Tuesday reported a loss of $19.9 million in its second quarter. Aug 12, 2025 - $MGX
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple